Southern Miss Fuels Biotech Growth in Mississippi
Southern Miss advances biomaterials research for immune disease treatment with a $2.5M collaboration, boosting Mississippi's biotech.
- Latest
- Trending
Southern Miss advances biomaterials research for immune disease treatment with a $2.5M collaboration, boosting Mississippi's biotech.
SeaTrac and USM team up for hypoxia mapping in Gulf waters using innovative uncrewed vehicles, advancing marine tech.
Choice Hotels posts record Q2 earnings with 22% growth in global room pipeline. Upscale growth and strategic expansions lead the ...
McLaren Health Care hit by another cyberattack, affecting IT and phone systems. Patient data safety still under review.
CyberArk Software sees 28% revenue growth and strong ARR boost, enhancing its leadership in identity security market.
Datadog reports strong Q2 revenue of $645M with 27% growth, adding 2,600 new customers and expanding product use.
Moody's downgrades Intel's rating to BAA1, citing profitability concerns and changes outlook to negative.
Paramount Global beats Q2 earnings expectations; stock rises 5.4% amidst revenue shortfall in challenging media market.
Dogecoin's growth slows as new addresses decline, affecting its price action amid rising competition in the meme coin market.
Brookfield's impressive Q2 results highlight growth in renewable energy and data centers, positioning for future success.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.